title: Nasal nicotine spray: a rapid nicotine delivery system.
abstract: Plasma nicotine concentrations following administration by two types of nasal nicotine spray were compared in ten subjects. Absorption was particularly rapid during the first 2.5 min, the average rise in blood nicotine concentrations during this time being 8.6 ng/ml for the two products, followed by a small further rise to an average peak increase of 10.5 ng/ml 5 min after the dose of 2 mg nicotine base (mean 27.8 micrograms/kg). Despite a four-fold Cmax variation between subjects, the levels of individual subjects were fairly consistent across the two products. There were no significant differences between the two products in blood nicotine concentrations or cardiovascular responses, and the correlation between the AUCs from the two products was 0.68 (P = 0.01). Eight subjects reported subjective feelings of light-headedness or slight dizziness, which are not typical after slower absorption from nicotine gum or skin patches. Blood nicotine levels within the smoking range were soon built up with repeated doses, even in the subject with the least efficient nasal absorption. In a second study of ad libitum use under clinical conditions both products appeared sufficiently acceptable for therapeutic use as an aid to smoking cessation. There was no tendency to escalate to excessive use over 4 weeks, and blood nicotine concentrations in nine subjects averaged only 44% of their prior smoking levels. Only one subject had levels equivalent to prior smoking and possible reasons why this was not more common are discussed.
authors.affiliation: ICRF Health Behaviour Unit, Institute of Psychiatry, London, UK.
authors.forename: G
authors.initials: G
authors.lastname: Sutherland
authors.forename: M A
authors.initials: MA
authors.lastname: Russell
authors.forename: J
authors.initials: J
authors.lastname: Stapleton
authors.forename: C
authors.initials: C
authors.lastname: Feyerabend
authors.forename: O
authors.initials: O
authors.lastname: Ferno
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D016503:Drug Delivery Systems; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009538:Nicotine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016540:Smoking Cessation
chemical_list: D009538:Nicotine